Literature DB >> 3029434

Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.

P R Carroll, W F Whitmore, H W Herr, M J Morse, P C Sogani, D Bajorunas, W R Fair, R S Chaganti.   

Abstract

In 15 patients with germ cell testicular tumors serum hormone profiles and semen analysis before orchiectomy were evaluated to determine the incidence of defective spermatogenesis associated with testicular tumors. Defective spermatogenesis was noted in 10 patients (66 per cent) on the basis of low sperm concentration, motility or semen volume. Of the 10 patients 7 had sperm concentrations less than 10 million per cc. Endocrine abnormalities occurred in 10 patients, the most common of which were elevations in serum human chorionic gonadotropin and estradiol, and a relative decrease in follicle-stimulating hormone. Three patients who presented with subfertile semen analyses were treated with orchiectomy alone. Repeat semen analyses 4 to 12 months after orchiectomy showed improvement in spermatogenesis and 2 patients achieved a normal semen analysis. Endocrine abnormalities and defective spermatogenesis are common in patients with testicular tumors. These abnormalities precede orchiectomy and imply that a primary germ cell defect exists in these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029434     DOI: 10.1016/s0022-5347(17)44054-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  The genetic and phenotypic basis of infertility in men with pediatric urologic disorders.

Authors:  Michael H Hsieh; Adam Hollander; Dolores J Lamb; Paul J Turek
Journal:  Urology       Date:  2010-05-07       Impact factor: 2.649

Review 2.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 3.  Effects of cancer and anti-neoplastic treatment on the human testicular function.

Authors:  A De Palma; E Vicari; I Palermo; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

Review 4.  Male Fertility Preservation.

Authors:  J Abram McBride; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

5.  Effects of anti-neoplastic treatment on sperm aneuploidy rate in patients with testicular tumor: a longitudinal study.

Authors:  N Burrello; E Vicari; S La Vignera; G Romeo; C Campagna; E Magro; D Giuffrida; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2010-07-29       Impact factor: 4.256

Review 6.  Anticancer chemotherapeutic agents and testicular dysfunction.

Authors:  Kohei Yamaguchi; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2011-03-17

7.  Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.

Authors:  Stefania Catalano; Rocco Malivindi; Cinzia Giordano; Guowei Gu; Salvatore Panza; Daniela Bonofiglio; Marilena Lanzino; Diego Sisci; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2009-12-21       Impact factor: 5.157

8.  Risk of testicular cancer in men with abnormal semen characteristics: cohort study.

Authors:  R Jacobsen; E Bostofte; G Engholm; J Hansen; J H Olsen; N E Skakkebaek; H Moller
Journal:  BMJ       Date:  2000-09-30

9.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

Review 10.  Preventable causes of male infertility.

Authors:  S T Thompson
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.